These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11975322)

  • 1. [Access of developing countries to essential drugs: a process of equity].
    Campion MD
    Bull Acad Natl Med; 2001; 185(7):1255-66; discussion 1266-9. PubMed ID: 11975322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GO License: only part of the solution.
    Batson A; Milstien JB
    Health Aff (Millwood); 2008; 27(1):140-2. PubMed ID: 18180489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 4. Legal and policy foundations for global generic competition: Promoting affordable drug pricing in developing societies.
    Zapatero Miguel P
    Glob Public Health; 2015; 10(8):901-16. PubMed ID: 25737069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Access for all to quality drugs].
    Videau JY
    Med Trop (Mars); 2002; 62(4):396-400. PubMed ID: 12534178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug prices may be too high despite WTO deal.
    Fleck F
    Bull World Health Organ; 2003; 81(10):774-5. PubMed ID: 14758442
    [No Abstract]   [Full Text] [Related]  

  • 7. Extension of market exclusivity and its impact on the accessibility to essential medicines, and drug expense in Thailand: analysis of the effect of TRIPs-Plus proposal.
    Akaleephan C; Wibulpolprasert S; Sakulbumrungsil R; Luangruangrong P; Jitraknathee A; Aeksaengsri A; Udomaksorn S; Tangcharoensathien V; Tantivess S
    Health Policy; 2009 Jul; 91(2):174-82. PubMed ID: 19150741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In wake of 9/11, drug-patent rules change.
    Cassels A
    CMAJ; 2002 Feb; 166(3):366. PubMed ID: 11868652
    [No Abstract]   [Full Text] [Related]  

  • 9. Reprivatizing pharmaceutical supplies in Africa.
    Turshen M
    J Public Health Policy; 2001; 22(2):198-225. PubMed ID: 11469153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taking TRIPS to India--Novartis, patent law, and access to medicines.
    Mueller JM
    N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
    [No Abstract]   [Full Text] [Related]  

  • 11. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
    Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
    Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High medicine prices and poor affordability.
    Suh GH
    Curr Opin Psychiatry; 2011 Jul; 24(4):341-5. PubMed ID: 21532479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIPS, pharmaceuticals, developing countries, and the Doha "solution".
    Sykes AO
    Chic J Int Law; 2002; 3(1):47-68. PubMed ID: 15709299
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug companies should cut prices for developing countries, says G8 report.
    Walgate R
    Bull World Health Organ; 2003; 81(1):72-3. PubMed ID: 12640481
    [No Abstract]   [Full Text] [Related]  

  • 15. Access to medicines and domestic compulsory licensing: learning from Canada and Thailand.
    Kuek V; Phillips K; Kohler JC
    Glob Public Health; 2011; 6(2):111-24. PubMed ID: 20234967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thailand and the compulsory licensing of efavirenz.
    Steinbrook R
    N Engl J Med; 2007 Feb; 356(6):544-6. PubMed ID: 17287474
    [No Abstract]   [Full Text] [Related]  

  • 17. Essential drugs in the new international economic environment.
    Velásquez G; Boulet P
    Bull World Health Organ; 1999; 77(3):288-92. PubMed ID: 10212525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary: will generic drug stores improve access to essential medicines for the poor in India?
    Kotwani A
    J Public Health Policy; 2010 Jul; 31(2):178-84. PubMed ID: 20535100
    [No Abstract]   [Full Text] [Related]  

  • 19. Innovation and the WHO's essential medicines list: giving credit where credit is due.
    Wertheimer AI; Santella TM
    Res Social Adm Pharm; 2007 Mar; 3(1):137-44. PubMed ID: 17350562
    [No Abstract]   [Full Text] [Related]  

  • 20. The responsibility of research universities to promote access to essential medicines.
    't Hoen EF
    Yale J Health Policy Law Ethics; 2003; 3(2):293-300. PubMed ID: 14577145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.